Pfizer COVID Vaccine Updates

News

GSK, Pfizer and CureVac

CureVac and GSK settle mRNA patent dispute with Pfizer and BioNTech

Germany's CureVac and Britain's GSK have settled a years-long patent dispute with Pfizer and its partner BioNTech over the mRNA vaccine technology that was at the forefront of the world's fight against COVID-19.

Seeking Alpha on MSN · 1d

GSK, CureVac to receive $740M as COVID vaccine patent dispute with Pfizer, BioNTech settled

CureVac (NASDAQ:CVAC) announced on Friday that the company and its partner, GSK (NYSE:GSK), are set to receive $740M and other payments, as Pfizer (NYSE:PFE) and BioNTech (NASDAQ:BNTX) have agreed to resolve a patent dispute related to messenger-RNA-based COVID vaccines in the U.

The Punch on MSN · 1d

Pfizer, BioNTech reach Covid jab settlement with GSK, CureVac

American pharmaceutical giant Pfizer and German biotech firm BioNTech will pay Britain s GSK and Germany s CureVac $740 million

Wall Street Journal · 1d

GSK to Receive $370 Million in U.S. Patent Litigation Settlement

The pharma giant will also receive a 1% royalty on future U.S. sales of influenza, Covid-19 and other related combination mRNA vaccine products made by BioNTech and Pfizer.

PA Media on MSN · 1d

GSK to be paid up to £370 million after patent row settles in US

CureVac – a German pharmaceutical company – settled a long-running patent dispute with rival BioNTech and Pfizer in the US on Thursday.

MedPage Today on MSN2d

Did FDA Pick the Wrong COVID Vaccine Strain Last Season? | MedPage Today

In Danes over age 65, the vaccine effectiveness of the JN.1-based mRNA boosters reached 70-85% against COVID-related hospitalization and 76-96% against COVID-associated death. Despite the shift away ...

Malay Mail1d

Covid vaccine patent fight finally ends: Pfizer-BioNTech to pay CureVac and GSK US$740m plus US sales royalties

American pharmaceutical giant Pfizer and German biotech firm BioNTech will pay Britain’s GSK and Germany’s CureVac US$740 ...

2don MSN

Are mRNA Vaccines Safe — and Should You Still Get a COVID Shot? Doctors on the Pros and Cons

RFK Jr. recently made major cuts to mRNA vaccine development research, questioning their safety. Should you still get the ...

3don MSN

HHS phases out mRNA vaccine trials for COVID-19, bird flu

HHS says the elimination of 22 mRNA vaccine development projects for COVID-19 and bird flu signals a shift in vaccine ...

8don MSN

Pfizer, BioNTech lose UK appeal to overturn Moderna's COVID vaccine patent win

Pfizer and its German partner BioNTech on Friday lost their bid to overturn a ruling that their COVID-19 vaccine infringed ...

14d

Pfizer (PFE) Receives CHMP Recommendation For Adapted COVID-19 Vaccine COMIRNATY

BioNTech SE and Pfizer (PFE) recently received a positive recommendation from the European Medicines Agency for marketing ...

KSAT1d

RFK Jr slashes $500 million in funding for mRNA vaccine research. What does it mean for the future of human health?

The federal government’s decision to slash $500 million in funding for mRNA vaccine research has sparked concern among health ...

3don MSN

HHS slashes funding for mRNA vaccine development

US Health and Human Services is “winding down” its mRNA vaccine development and will instead fund other vaccine platforms ...

ABC News4y

The reality behind Pfizer’s COVID-19 vaccine distribution plan

A technician inspects vials of coronavirus disease (COVID-19) vaccine candidate BNT162b2 at a Pfizer manufacturing site in manufacturing site in St. Louis, Missouri, U.S. in an undated ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results